Search Results
NACFC 2018 | Plenary 1: Improving Outcomes of Infections in the Age of CFTR Modulators
NACFC 2018 | Plenary 2: Anti-Inflammatories and Mucociliary Clearance Therapies
Research Updates from the 2018 North American Cystic Fibrosis Conference (NACFC)
NACFC 2018 | Plenary 3: Partnering: The Oldest New Idea to Improve CF Care
NACFC 2020 | S10: CFTR Modulators: What We Are Learning
NACFC 2021 | S20: Promoting Healthy Living in the Era of CFTR Modulators: Where Do We Begin
CF Foundation | NACFC Highlights and Q+A
NACFC 2024 | W01: Effect of CFTR Modulator Therapy on Infection and Inflammation in CF
CF Foundation | 2017 NACFC Plenary 1: Matching Medicines With Mutations
NACFC 2021 | S09: Highly Effective CFTR Modulators in the Post-FDA Approval World
NACFC 2021 | Plenary 3: Expanding the Horizon of Therapies for the Underlying Cause of CF
NACFC 2024 | W38: Epidemiology and Management of Infection in CF
